Clinical trials
Terminated Phase 3 Pain trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
80 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 5 |
| 2004 | 1 |
| 2005 | 7 |
| 2006 | 11 |
| 2007 | 5 |
| 2008 | 6 |
| 2009 | 6 |
| 2010 | 5 |
| 2011 | 3 |
| 2012 | 5 |
| 2013 | 9 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2020 | 1 |
| 2021 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 80 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 4 |
| Pfizer | 4 |
| Grünenthal GmbH | 3 |
| ZARS Pharma Inc. | 3 |
| Endo USA Inc., a Keenova Therapeutics Company | 2 |
| Hoffmann-La Roche | 2 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2 |
| Mayo Clinic | 2 |
| Pacira Pharmaceuticals, Inc | 2 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pain | 80 |
| Neoplasms | 9 |
| Chronic Pain | 8 |
| Bronchiolitis Obliterans Syndrome | 5 |
| Constipation | 5 |
| Osteoarthritis | 5 |
| Agnosia | 4 |
| Breast Neoplasms | 4 |
| Opioid-Induced Constipation | 4 |
| Postoperative Pain | 4 |
Trials
Showing 1 to 25 of 80. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.